MERCK $47.33

up +0.62


23/5/2013 04:23 PM  |  NYSE : MRK  |  Industries : Manufacturing / Pharmaceutical and Medicine Manufacturing
12 Mo. Price Change : 26% - MRK has outperformed the S&P 500 by 1%

Get Trend Analysis Icon Get Trend Analysis

Partner Headlines

  1. Only $688 Million to Make Merck's Vytorin Mess Go Away? Seems ...

    YCharts

  2. Merck agrees to pay $688 mil

    Investors Business Daily

  3. Merck Pays $688M to Settle Investor Suit

    FOXBusiness

  4. Odd, This: Big Pharma On Losing End of Pricing Dispute

    YCharts

  5. Short Interest Swings in Biotech Stocks (AMGN, CELG, ONXX)

    Benzinga

  6. Pharma's Pay-to-Delay Deals Face Further Opposition: Senate Bill ...

    YCharts

  7. Weekly Contrarian: Merck Bulls Should Be On Guard

    By SchaeffersResearch

  8. Huh? After Laying Off 150,000, Big Pharma Says Finding Talent Has ...

    YCharts

  9. Merck Serono, Opexa Therapeutics Enter Option, License Agreement ...

    Benzinga

  10. Is My Doctor On the Payroll of Some Drug Maker? Now Easier to Find Out

    YCharts

  11. UPDATE: BMO Capital Markets Reiterates Outperform Rating, Lowers ...

    Benzinga

  12. Merck Delays Drug Approval

    Investors Business Daily

  13. Buzz Stocks: Merck, Pfizer, General Motors, and Sony

    By SchaeffersResearch

  14. Pay-to-Delay Opponent, FTC Chief Leibowitz, Quits: Respite for Pharma?

    YCharts

  15. Stock Futures Rally on Global Economic Optimism

    FOXBusiness

  16. Merck Posts 4Q Beat

    FOXBusiness

  17. US Stock Futures Up; All Eyes On Payroll Data

    Benzinga

  18. Earnings Scheduled For February 1, 2013

    Benzinga

  19. Stocks To Watch For February 1, 2013

    Benzinga

  20. 2013: Breakout or Comeuppance?

    GuruFocus

  21. 10-year Shiller P/E Exposes Cyclical Overvaluation and Undervaluation

    GuruFocus

  22. Jobs Data, FOMC Meeting on Tap Next Week

    FOXBusiness

  23. FDA Approves OXYTROL for Women

    Benzinga

  24. Claman's Davos Notebook: Big Names, Bigger Ideas

    FOXBusiness

  25. Claman's Davos Notebook: Who's Who

    FOXBusiness

  26. Boeing's Dreamliner Woes an Opportunity

    GuruFocus

  27. FTC: Pay-to-Delay Pharma Deals Cover $8.3 Billion in Revenue

    YCharts

  28. UPDATE: Jefferies & Company Reiterates Hold Rating, Lowers PT on ...

    Benzinga

  29. Three Stocks to Buy for Flu Season

    Benzinga

  30. Pharma Flop: Story Behind Merck's Failed Cholesterol Pill

    YCharts

  31. Merck Starts Pulling Tredaptive From Global Markets

    Investors Business Daily

  32. Merck to Suspend Availability of TREDAPTIVE Worldwide

    Benzinga

  33. Merck Option Traders Bet On Additional Downside

    By SchaeffersResearch

  34. Microbiotix, Merck Announce Licensing Pact for HCV NS5B

    Benzinga

  35. 4 Health Care ETFs Your Broker Forgot to Mention

    Benzinga

  36. Do Pharma Stocks Deserve Takeover Premiums? Read This First

    YCharts

  37. The Best-Yielding Stocks from the Dow Jones and Nasdaq 100

    GuruFocus

  38. Merck Says FDA Acknowledged Resubmission of NDA for Ezetimibe, ...

    Benzinga

  39. ResMed CEO Farrell Not Sleeping Easy With 2013 Here

    Investors Business Daily

  40. Parexel Makes Buyout, Lifts Outlook, But Stock Slips

    Investors Business Daily

  41. Parexel CEO Says 'New Era' For Pharma Has Arrived

    Investors Business Daily

  42. The Best Dogs of the Dow Jones as of December 2012

    GuruFocus

  43. Failure City: Pharma Eats Up R&D Budgets Trying to Make Drugs to ...

    YCharts

  44. Abbott Laboratories: Quality Dividend Aristocrat for Long Term ...

    GuruFocus

  45. Traders Place Short-Term Bearish Bets as Merck Retreats

    By SchaeffersResearch

  46. Merck sees drug safety issues

    Investors Business Daily

  47. Mid-Morning Market Update: Rite Aid Rallies, New York Stock ...

    Benzinga

  48. Merck Says HPS2-THRIVE Study of TREDAPTIVE Did Not Achieve Primary ...

    Benzinga

  49. With Influence Like This, You'd Expect Pharma Stocks to Do Better

    YCharts

  50. Merck, GE Healthcare Announce Collaboration on Use of Imaging ...

    Benzinga

  51. These 2 Dow Laggards Could Rebound in 2013

    Benzinga

  52. Lilly Stock Falls As Alzheimer's Drug Needs New Trial

    Investors Business Daily

  53. Benzinga's Small Cap Movers for Tuesday December 11, 2012

    Benzinga

  54. Benzinga's M&A Chatter for Tuesday December 11, 2012

    Benzinga

  55. Cardiome Reaches Deal with Merck to Retire Debt/Close Line of ...

    Benzinga

  56. Amgen buys DeCode Genetics

    Investors Business Daily

  57. Three More Defensive Stock Picks for 2013 (LLY, PFE, VTR)

    Benzinga

  58. Amgen Buying DeCode Genetics To Find Targeted Drugs

    Investors Business Daily

  59. Barron's Recap (12/8/12): Ten Stock Picks for 2013

    Benzinga

  60. Stem Cell Research Gets Boost From New Cell Bank

    Investors Business Daily

  61. How Big Pharma Might Get Its R&D Act Together

    YCharts

  62. Merck races to beat Lilly debut

    Investors Business Daily

  63. Alzheimer Failures Elsewhere Don't Deter Merck: Phase II/III Study ...

    YCharts

  64. This Company Is Spicing Up Its Dividend with Another Increase

    GuruFocus

  65. Merck Alzheimer's Drug Trial Challenges Lilly's Lead

    Investors Business Daily

  66. Accenture Life Sciences Study: Worst of Pharma's Patent Cliff is ...

    YCharts

  67. If Only People Would Take Their Meds – Pharma Sales Might Double

    YCharts

  68. The Best Dogs of the Dow Jones as of November 2012

    GuruFocus

  69. Generics Maker Teva Pharmaceutical to Make Smaller Acquisitions, ...

    YCharts

  70. Benzinga's Top Upgrades

    Benzinga

  71. Dynavax: Little Stock With a Big Story – Plunge a Buy Opportunity?

    YCharts

  72. S&P Reiterates Bullish View on Health Care ETFs

    Benzinga

  73. Big Pharma Gains Another Foe on Pay-to-Delay Deals: 31 State A.G.s ...

    YCharts

  74. More Trouble for Big Pharma Stocks: AMA Calls for an End to ...

    YCharts

  75. These ETFs Offer Solid Yield in Uncertain Times

    Benzinga

  76. Short Interest Swings in Biotech Stocks (AMGN, BIIB, VRTX)

    Benzinga

  77. Pharma's Off-Label Violations Not Limited to the U.S.: Glaxo's ...

    YCharts

  78. Weekly Top Insider Sells: KSS, AMG, MRK, VRX, and AXP

    GuruFocus

  79. UPDATE: BMO Capital Markets Upgrades Merck & Co. to Outperform, ...

    Benzinga

  80. Big Pharma on the Defensive: Sanofi Caves on Oncology-Drug, ...

    YCharts

  81. Study on AZN's Seroquel Might Have Warned Pentagon Off Big Use of ...

    YCharts

  82. Mylan To Wall Street: Forget Patent Cliff, We'll Grow

    Investors Business Daily

  83. Futures Flat, Euro Falls Ahead of Central Banks

    Benzinga

  84. Amgen Cholesterol-Fighter Shows Promise, Shares Rise

    Investors Business Daily

  85. Take an Out-of-Work Drug Rep to Lunch: More Big Pharma Layoffs

    YCharts

  86. China Drug Market to Boom – Diabetes Alone a $3.2 Billion Business ...

    YCharts

  87. No-Go on Hepatitis Drug Patent in India: More Developing-Country ...

    YCharts

  88. Moves in Smaller Health Care Stocks (GMED, SEM, UAM, VRTX)

    Benzinga

  89. Merck's Mighty Januvia: The Diabetic Investor Explains a Huge, ...

    YCharts

  90. Watson Pharma Starts New Era As Generic Drug Titan

    Investors Business Daily

  91. More Equal-Weight ETFs Your Broker Forgot to Mention

    Benzinga

  92. Analyst Upgrades: Merck and Comcast

    By SchaeffersResearch

  93. Parexel Earnings Seen Growing 45% In Fiscal Q1

    Investors Business Daily

  94. More Quality Problems at Johnson & Johnson (Odious Details Omitted)

    YCharts

  95. UPDATE: BMO Capital Markets Reiterates Market Perform Rating, ...

    Benzinga

  96. Merck EPS beats, sales miss

    Investors Business Daily

  97. Stocks Cap Week in the Red as Earnings Weigh

    FOXBusiness

  98. The Best Dogs of the Dow Jones with Highest EPS Growth as of ...

    GuruFocus

  99. Pharma Merck Earnings Beat Estimates, Revenue Misses

    Investors Business Daily

  100. Merck 3Q EPS Tops Street View, Sales Fall Short

    FOXBusiness
People viewing MRK also viewed: , , , , , ,
Marketplace
Trading Center